Senior fellow at the Japan Science and Technology Agency (JST). And former Denso Europe President and CTO. He has lived overseas for a long time and is knowledgeable about industry-academia collaboration and open innovation especially in the German automotive industry.

After the Director of Rakuten, Inc. She joined the startup company as Co-founder and COO. Later, she was involved in new business development with investments at Macnica, a technology trading company.
She has extensive business development experience and a broad network in the digital industry.

As a global corporate venture manager in Silicon Valley, he connected technologies from Japan and the US through formation of partnerships and conducted business and technological due diligence for startups. He returned to Japan in 2016 after living abroad for 30 years in total. He is Senior Director of Investment Strategy, Portfolio Development and Innovations in a public-private partnership fund for the development of drugs, vaccines and diagnostics for developing countries.

After working in investment banking for Goldman Sachs, she worked for the Inter-American Development Bank in Washington DC for 15 years mainly focused on its Project Finance.
Upon return to Japan in 2014, she established IMPACT ACCESS corporation.
She advises new business strategy for corporate/organizational leaders and leads new business operations for varied innovation sector projects, utilizing her international business experience and applying open innovation & design thinking based approaches.
The University of Tokyo-Softbank Joint Venture “Beyond AI” Project “Institute for AI and Beyond” Organizing Task Force Director Tokai Tokyo Financial Holdings CSR program “Chubu Open Innovation College” Director
Visiting researcher at the Institute of Future Initiatives.

Worked for the Industrial Bank of Japan (IBJ) for over 20 years as international investment banker. Then worked for Privat Equity funds (PE funds) for 10 years, inclusive of Japan Industrial Partners (JIP) as Managing Director, and Hiroshima Innovation Network (public-private investment fund of Hiroshima Prefecture) as CEO.
Currently, Founder & CEO of Tri-Wins Inc, a consulting firm of executive search and financial advisory services.

At the Hiroshima Prefectural Office, Mr. Kushioka established a public-private fund and was responsible for creating measures for promoting innovation and facilitating industry-academia-government partnerships. At Hiroshima University, he was in charge of the Cabinet Office’s Regional University/Regional Industry Revitalization Grant. He served on the innovation promotion committee for the industry-academia collaboration and regional support groups for science and technology operated by the Council for Science and Technology (9th and 10th terms).

Engaged in research and development of wood biomass and water-based polymers at a domestic manufacturing company. Later, I was engaged in the management of a global retailer, from the start-up of an in-store recycling business to business operations.
Since 2024 I have been engaged as a creative manager at Hiroshima University.

Graduated from Faculty of Engineering, Kyoto University and Graduate School of Engineering, Kyoto University.

Served as head of organization from basic research to product development in a global manufacturing company. Engaged in leading R&D and formulating mid- to long-term R&D plans, business plans, etc.

He has been engaged in pharmacokinetic/drug delivery system research and drug development work (preparation of application materials, etc.) at a Japanese pharmaceutical company for about 34 years.
He has been a creative manager at Hiroshima University since 2023.

Worked for an industrial machinery trading company for about 9 years. Engaged in providing consistent services from equipment needs assessment to after-sales maintenance for both private and government sectors.

Dr. Hashimoto has been engaged in research and development at Mitsubishi Heavy Industries, Ltd. since he joined the company and he served as Director of Hiroshima R&D Center. At Hiroshima University, he was involved in industry-academia collaboration activities for 14 years, and served as Director of the Center for Collaborative Research and Community Cooperation, where he contributed to starting numerous large-scale joint research projects.

Engaged in drug discovery research (small molecule drugs/antibody therapeutics) at a Japanese pharmaceutical company for about 16 years. His areas of expertise include allergy, immunology and oncology. After participating in research projects and consortium of overseas organizations including Johns Hopkins University School of Medicine (USA) and the National Health Research Institutes (Taiwan), he’s served since 2018 as an industry-academia-government collaboration coordinator at Hiroshima University.